combined BRAF-MEK inhibitors
Results Trial description recap V1

Encorafenib plus binimetinib - Vemurafenib and cobimetinib


Melanoma

all type of patients 7 trials

adjuvant setting 2 trials

- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons